Lumos Pharma Stock (NASDAQ: LUMO) stock price, news, charts, stock research, profile.
Open | $2.744 |
Close | $2.770 |
Volume / Avg. | 688.000 / 19.900K |
Day Range | 2.744 - 2.780 |
52 Wk Range | 2.410 - 4.550 |
Market Cap | $23.375M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 5.02% |
Days to Cover | 20.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lumos Pharma (NASDAQ: LUMO) through any online brokerage.
Other companies in Lumos Pharma’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Lumos Pharma (NASDAQ: LUMO) was reported by HC Wainwright & Co. on Wednesday, March 20, 2024. The analyst firm set a price target for 28.00 expecting LUMO to rise to within 12 months (a possible 872.22% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Lumos Pharma (NASDAQ: LUMO) is $2.88 last updated April 24, 2024 at 9:27 AM EDT.
There are no upcoming dividends for Lumos Pharma.
Lumos Pharma’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Lumos Pharma.
Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.